Inclusion Criteria:  multiple sclerosis clinical eligibility to treatment with Natalizumab no previous exposure to Natalizumab treatment  Exclusion Criteria:  inability to perform an MRI with contrast inability to undergo a paper-pencil questionnaires and blood work